Grant: DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
University of Toronto
$120,000.00
Epigenetic dynamics of small cell lung cancer during therapy
FY 2025-26
Summary
Small cell lung cancer (SCLC) is a fast-growing cancer that remains a devastating diagnosis. Most patients respond at first to chemotherapy, but quickly relapse, and fewer than 7% live five years. One reason may lie in how DNA is packaged. DNA is wrapped around proteins called histones, which can carry chemical tags that turn genes on or off. One such tag, H3K27me3, has been linked to treatment resistance. Other tags, such as DNA methylation and DNA hydroxymethylation, also shape whether genes are silenced or active. Together, understanding these "epigenetic marks" may enable us to uncover why tumours become resistant to therapy.
My project uses a blood test, or liquid biopsy, to track these epigenetic marks in tumour DNA over time. Tumours release fragments of DNA into the bloodstream, and new methods allow us to map where these marks sit on tumour DNA. I will profile H3K27me3 patterns in newly diagnosed SCLC patients and combine this information with DNA methylation and DNA hydroxymethylation data to build a map of epigenetic marks in SCLC. Next, I will compare samples taken before treatment and at relapse and identify changes linked to resistance and test whether they can predict which patients relapse sooner. Finally, I will explore whether these blood tests can monitor the effects of drugs that target epigenetic pathways.
This work could yield practical blood-based tools to predict relapse, guide therapy, and aid the development of new treatments for patients with SCLC.
Department
Program
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
559732
Name
Aamir Aleem
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
DT1 (Biomedical and/or Clinical Research) CGRS Doctoral
Projecttitle
Epigenetic dynamics of small cell lung cancer during therapy
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
DRA : Canada Graduate Research Scholarship - Doctoral Program (CGRS D)
Keyworddelim
Cancer Biology; Cell-Free Dna; Chromatin; Epigenetics; H3k27me3; Histone Modifications; Liquid Biopsy; Pharmacodynamics; Small Cell Lung Cancer; Treatment Resistance
Abstract
Small cell lung cancer (SCLC) is a fast-growing cancer that remains a devastating diagnosis. Most patients respond at first to chemotherapy, but quickly relapse, and fewer than 7% live five years. One reason may lie in how DNA is packaged. DNA is wrapped around proteins called histones, which can carry chemical tags that turn genes on or off. One such tag, H3K27me3, has been linked to treatment resistance. Other tags, such as DNA methylation and DNA hydroxymethylation, also shape whether genes are silenced or active. Together, understanding these "epigenetic marks" may enable us to uncover why tumours become resistant to therapy.
My project uses a blood test, or liquid biopsy, to track these epigenetic marks in tumour DNA over time. Tumours release fragments of DNA into the bloodstream, and new methods allow us to map where these marks sit on tumour DNA. I will profile H3K27me3 patterns in newly diagnosed SCLC patients and combine this information with DNA methylation and DNA hydroxymethylation data to build a map of epigenetic marks in SCLC. Next, I will compare samples taken before treatment and at relapse and identify changes linked to resistance and test whether they can predict which patients relapse sooner. Finally, I will explore whether these blood tests can monitor the effects of drugs that target epigenetic pathways.
This work could yield practical blood-based tools to predict relapse, guide therapy, and aid the development of new treatments for patients with SCLC.
Competitiondate
202511
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Aamir, Aleem
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~